Aethlon Medical Inc
AEMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000882291
No open-market purchases or sales by Aethlon Medical Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $218.1K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Aethlon Medical Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −12 vs. Q3 2025
- Shares held
- 16.5K
- −504.5K (−96.8%) vs. Q3 2025
- Total value
- $45.6K
- −$343.7K (−88.3%) vs. Q3 2025
- New holders
- 0
- 1 more added
- Sold out
- 12
- 7 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $218.1K |
| Q1 2026 | 12 | $155.0K |
| Q4 2025 | 8 | $45.6K |
| Q3 2025 | 20 | $389.3K |
| Q2 2025 | 17 | $481.3K |
| Q1 2025 | 25 | $1.21M |
| Q4 2024 | 24 | $1.38M |
| Q3 2024 | 19 | $186.8K |
| Q2 2024 | 18 | $89.2K |
| Q1 2024 | 10 | $87.3K |
| Q4 2023 | 12 | $113.7K |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Aethlon Medical Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 14,364 | $39.8K | 0.01% | −139,295−90.7% | Reduced |
| Morgan Stanley | 2,047 | $5.67K | 0.00% | +2,038+22,644.4% | Added |
| Citigroup Inc | 33 | $91 | 0.00% | −2,430−98.7% | Reduced |
| Group One Trading, L.P. | 14 | $39 | 0.00% | −137−90.7% | Reduced |
| BlackRock, Inc. | 10 | $28 | 0.00% | −84−89.4% | Reduced |
| Bank of America Corp | 6 | $17 | 0.00% | −15−71.4% | Reduced |
| Wells Fargo & Company | 3 | $7 | 0.00% | −23−88.5% | Reduced |
| Danske Bank A/S | 1 | $3 | 0.00% | −2−66.7% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −130,601−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −95,084−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −25,988−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −20,270−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,492−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,682−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −13,468−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,992−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Bartlett & Co. Wealth Management LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold out |